Syros Pharmaceuticals - 53 Year Dividend History | SYRS
Historical dividend payout and yield for Syros Pharmaceuticals (SYRS) since 1971. The current TTM dividend payout for Syros Pharmaceuticals (SYRS) as of November 29, 2024 is $0.00. The current dividend yield for Syros Pharmaceuticals as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.007B |
$0.010B |
|
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
